Target intelligence / Profile preview

Mycobacterial F₁F₀ ATP synthase (ATP synthase)

Target
ATP synthase
Molecular classification
Enzyme, ATPase, Oxidative phosphorylation complex
01

Overview

Mycobacterial F₁F₀ ATP synthase is a multi-subunit enzyme complex essential for the energy metabolism of mycobacteria, including Mycobacterium tuberculosis [1, 4]. It functions as the primary catalyst for adenosine triphosphate (ATP) synthesis via oxidative phosphorylation, utilizing the proton motive force generated by the electron transport chain [2, 5]. The enzyme consists of a membrane-embedded F₀ sector involved in proton translocation and a cytoplasmic F₁ sector where ATP is synthesized from ADP and inorganic phosphate [5, 12]. This target is particularly vital because mycobacteria rely on it for survival during both active growth and latent phases of infection [4, 12]. The clinical significance of this target was established with the approval of bedaquiline, a diarylquinoline that selectively binds to the c-ring of the mycobacterial F₀ sector [6, 9]. This interaction inhibits the rotation of the enzyme, leading to a rapid depletion of ATP and subsequent bacterial death [9, 13]. While bedaquiline is a cornerstone in treating multidrug-resistant tuberculosis, its use is associated with safety concerns such as QTc prolongation and potential hepatotoxicity [1, 11]. Research continues into next-generation inhibitors like TBAJ-876, which aim to provide improved safety profiles and broader efficacy against non-tuberculous mycobacteria [2, 6].

Other names
F-type ATPaseH+-transporting ATP synthaseMycobacterial F-ATP synthaseF1F0-type ATP synthaseATP synthase complex
02

Mechanism of action

Inhibition of the c-ring rotation within the F0 sector, which halts the catalytic activity of the F1 sector and depletes cellular ATP levels.

03

Biological functions

ATP synthesisOxidative phosphorylationProton translocationMaintenance of membrane potentialEnergy metabolism
04

Disease associations

InfectionTuberculosisMultidrug-resistant tuberculosisNon-tuberculous mycobacterial infection
05

Safety considerations

QTc prolongationHepatotoxicityDrug resistance development (e.g., atpE or mmpR5 mutations)Delayed bactericidal activity
06

Interacting drugs

Bedaquiline

4 more in the full profile.

07

Biomarkers

atpE gene mutationsSputum culture conversionMinimum Inhibitory Concentration (MIC)Intracellular ATP levels

Beyond the preview

Go deeper on Mycobacterial F₁F₀ ATP synthase (ATP synthase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial F₁F₀ ATP synthase (ATP synthase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call